Diabetes MellitusNCT00368095
Rajavithi Health Promotion Project (Population Base Cohort)
An observational study of Diabetes Mellitus and Hypertension, run by Department of Medical Services Ministry of Public Health of Thailand at 1 site in Thailand.
Trial summary
Metabolic Syndrome (hypertension, diabetes mellitus, obesity, cerebrovascular-cardiovascular disease) In Community Survey was performed in central Bangkok. Prospective Cohort and intensive educated intervention (health promotion program in specific high risk groups) were performed. Read more about this study
- Who is it for?
- Ages 16 to 120 yearsHealthy volunteers can take part
- Conditions the study is for
- Diabetes Mellitus, Hypertension, Dyslipidemia
- What is being tested?
- Intensive Education for Metabolic Syndrome Patients
- Type of treatment
- Lifestyle or therapy programme
- How many people
- 2,000 participants
- Where
- 1 siteThailand
- Study dates
- Aug 2006to Dec 2026
- Phase
- Observational
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 16 to 120 years
- All sexes
- Healthy volunteers accepted
- Child, Adult, Older adult
Study population: General population in Dindang destrict Bangkok
Who may be able to join
- Age 16 years or more
- Informed consent
- Living in selected community (Health Promotion area of Rajavithi Hospital)
Who cannot join
None listed.
Trial locations and contacts
1 site in 1 country.
About this study
Official title: The Rajavithi Prospective Cohort Study on Community's Member Health (HPH-cohort Study)
Metabolic Syndrome (hypertension, diabetes mellitus, obesity, cerebrovascular-cardiovascular disease) In Community Survey was performed in central Bangkok.
Prospective Cohort and intensive educated intervention (health promotion program in specific high risk groups) were performed. The aim of the study is to identify high risk patients who can develop serious complications from metabolic syndrome. An analysis of health outcomes in multiple dimensions will be performed.
- Conditions
- Diabetes Mellitus, Hypertension, Dyslipidemia, Obesity, Cardiovascular Disease, Coronary Artery Disease
- Being tested
- Intensive Education for Metabolic Syndrome Patients
- Keywords
- DM, HT, Dyslipidemia, Obesity, Cardiovascular disease, Cerebrovascular disease, Myocardial infarction, stroke, Metabolic syndrome, CVD-CAD
- Medical subject headings
- Diabetes Mellitus, Hypertension, Dyslipidemias, Obesity, Cardiovascular Diseases, Coronary Artery Disease, Cerebrovascular Disorders, Myocardial Infarction
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Intensive Education for Metabolic Syndrome PatientsBehavioural
Also called Patient with Metabolic Syndrome will be advised fro improve health status and genetic test will be apply
Excercise, Intensive diatary program
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted24 Aug 2006 (estimated)
- Study startAug 2006
- Primary completionDec 2026 (estimated)
- Study completionDec 2026 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Diabetes MellitusStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Prospective
- Enrolment
- 2,000 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Department of Medical Services Ministry of Public Health of Thailand
- Sponsor type
- Other government
- Collaborators
- U.S. Department of Education
- Responsible party
- Sponsor
- Investigators
- Subsai Kongsaengdao, Principal investigator, Department of Medical Services Ministry of Public Health of ThailandPiyathida Harnsomboonrana, M.D., Study director, Department of Medical Services Ministry of Public Health of ThailandWilai Pauvilai, M.D., Study chair, Department of Medical Services Ministry of Public Health of Thailand
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT00368095
- Sponsor's protocol ID
- RVH_CER_004
- Status last verified
- Apr 2022
- First submitted
- 23 Aug 2006
- Last updated
- 6 May 2022
- Results posted
- No
Study at a glance
From the registry record, last updated by the sponsor on 6 May 2022. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- The Rajavithi Prospective Cohort Study on Community's Member Health (HPH-cohort Study)
- ClinicalTrials.gov ID
- NCT00368095
- Acronym / sponsor ID
- RVH_CER_004
- Conditions
- Diabetes Mellitus, Hypertension, Dyslipidemia, Obesity, Cardiovascular Disease, Coronary Artery Disease
- Keywords
- DM, HT, Dyslipidemia, Obesity, Cardiovascular disease, Cerebrovascular disease, Myocardial infarction, stroke
- Study type
- Observational
- Recruitment status
- Active, not recruiting
- Enrolment
- 2,000 participants (estimated)
- Lead sponsor
- Department of Medical Services Ministry of Public Health of ThailandOther government
- Collaborators
- U.S. Department of Education
- Study start
- Aug 2006 (actual)
- Primary completion
- Dec 2026 (estimated)
- Study completion
- Dec 2026 (estimated)
- First posted
- 24 Aug 2006 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Metabolic Syndrome (hypertension, diabetes mellitus, obesity, cerebrovascular-cardiovascular disease) In Community Survey was performed in central Bangkok.
Prospective Cohort and intensive educated intervention (health promotion program in specific high risk groups) were performed. The aim of the study is to identify high risk patients who can develop serious complications from metabolic syndrome. An analysis of health outcomes in multiple dimensions will be performed.
Study design
- Observational model
- Cohort
- Time perspective
- Prospective
Who may qualify
- Ages
- 16 to 120 years
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Child, Adult, Older adult
- Study population
- General population in Dindang destrict Bangkok
Key inclusion criteria (3 listed)
- Age 16 years or more
- Informed consent
- Living in selected community (Health Promotion area of Rajavithi Hospital)
Key exclusion criteria (0 listed)
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Intensive Education for Metabolic Syndrome PatientsAlso: Patient with Metabolic Syndrome will be advised fro improve health status and genetic test will be applyExcercise, Intensive diatary program | Behavioural | – |
Primary outcome
Not reported in the source record.
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 6 May 2022.
Related trials for Diabetes Mellitus
Not yet recruitingPhase 3
Efficacy and Safety of Once-Weekly SHR-3167 Compared With Once-Daily Insulin Glargine in Adults With Insulin-Naive Type 2 Diabetes
Type 2 Diabetes
Active, not recruiting
Digital Reinforcement of Motivational Interviewing Micro-Skills Among Primary Care Healthcare Professionals
Hypertension (Without Type 2 Diabetes Mellitus)
Recruiting
Effects of Lean Pork Loin Intake on Protein Homeostasis and Glucose Regulation in Prediabetic Adults
Hyperglycaemia (Non Diabetic), Prediabetes
Recruiting
PAW-Hydrogel for Chronic Wound Healing
Diabetic Foot Ulcer (DFU), Pressure Ulcer (PU)
Recruiting
Investigating Vascular Properties of HEMI and SPG Signals in Individuals With or at Risk for Chronic Kidney Disease
Chronic Kidney Disease, Hypertension (HTN)
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Subsai Kongsaengdao principal investigator
Department of Medical Services Ministry of Public Health of Thailand
Piyathida Harnsomboonrana, M.D. study director
Department of Medical Services Ministry of Public Health of Thailand
Wilai Pauvilai, M.D. study chair
Department of Medical Services Ministry of Public Health of Thailand
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Diabetes Mellitus and Hypertension, run by Department of Medical Services Ministry of Public Health of Thailand at 1 site in Thailand.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 3 inclusion and 0 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: under way, not looking for participants, as of the sponsor's last update on 6 May 2022. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Thailand. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 6 May 2022.